Our Pipeline

KYE is committed to bringing value to Canadians with medicines that fulfill clinically significant needs that have not been met in Canada. With a number of lead product candidates in vascular health, pediatrics, dermatology, immunology, and other therapeutic areas, KYE is poised to become a major contributor to improving the health of Canadians in a meaningful way in the near future. KYE also believes strongly in listening closely to Canadians to meet our commitment to fulfilling the unmet needs of both health care professionals and patients. If you currently are a patient or a health care professional experiencing sub-optimal care or lack of options in practice due to a specific medicine not being available in Canada, please contact us. It is our mission to evaluate all opportunities that will improve the lives of Canadians.

2022
Immunology
Q3
2022
2023
Pediatrics
Q2
2023
2023
Hematology
Q3
2023
2023
Cardiology
Q4
2023
2024
Pediatrics
Q2
2024